|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Adjuvant chemohormonal therapy for primary breast cancer should be sequential instead of concurrent:initial results from intergroup trial 0100 (SWOG-8814)显示文摘 | Albain KS Green S J Ravdin PM | 2002 | Proc Am Soc Clin Oncol2002，21，： | 1 |
| 2 | Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with nodepositive, oestrogen- receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial显示文摘 | Albain KS Barlow WE Shak S | 2010 | Lancet Oncol2010，11，1： | 1 |
| 3 | Prognostic andpredictive value of the 21-gene recurrence score assay inpostmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy : a retrospective analysisof a randomised trial显示文摘 | Albain KS Barlow WE Shak S | 2010 | Lancet Oncol2010，11，1： | 1 |
| 4 | Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randonfised trial显示文摘 | Albain KS Barlow WE Shak S | 2010 | Lancet Oncol2010，11，1： | 1 |
| 5 | Prognostic and predictive value of the 21-gene Recurrence Score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomized trial显示文摘 | Albain KS Barlow WE Shak S | 2010 | Lancet Oncol2010，11，： | 1 |
| 6 | Prognostic and predictive value of the 21 - gene recurrence score assay in postmenopansal women with node - positive, estrogen - receptor - positive breast cancer on chemotherapy:A retrospective analysis of a randomised trial显示文摘 | Albain KS Barlow WE Shak S | 2010 | Lancet Oneol2010，11，1： | 1 |
| 7 | Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity,and disease-free survival in SWOG 8897 clinical trial for breast cancer显示文摘 | Yao S Barlow WE Albain KS | 2010 | Clin Cancer Res2010，16，24： | 1 |
| 8 | Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation 显示文摘 | Grudzien P Lo S Albain KS | 2010 | Anticancer Res2010，30，10： | 1 |
| 9 | Prognostic and predictive val- ue of the 21-gene recurrence score assay in postmenopausal worn- en with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial显示文摘 | Albain KS Barlow WE Shak S | 2010 | Lancet Oncol2010，11，1： | 1 |
| 10 | Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive,oestrogen-receptor-positive breast cancer on chemotherapy:a retrospective analysis of a randomised trial显示文摘 | Albain KS Barlow WE Shak S | | 0，，01： | 1 |
| 11 | Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive,oestrogen-receptor-positive breast cancer on chemotherapy:a retrospective analysis of a randomised trial显示文摘 | Albain KS Barlow WE Shak S | | 0，，01： | 1 |
| 12 | Global phase Ⅲ study of gemcitabine plus paclitaxel(GT) vs paclitaxel(T) as frontline therapy for metastatic breast cancer(MBC):First report of overall survival显示文摘 | Albain KS Nag S Calderillo-Ruiz G | 2004 | Proc Am Soc Clin Oncol2004，23，： | 1 |
| 13 | Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial 显示文摘 | Albain KS Barlow WE Shak S | 2010 | Lancet Onco12010，11，1： | 1 |
| 14 | Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestro- gen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial显示文摘 | Albain KS Barlow WE Shak S | 2010 | Lancet Oncol2010，11，1： | 1 |
| 15 | Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a ran- domised trial显示文摘 | Albain KS Barlow WE Shak S | 2010 | Lancet Oncol2010，11，1： | 1 |
| 16 | Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node positive, oestrogen receptor-positive breast cancer on chemotherapy:a retrospective analysis of a randomised trial 显示文摘 | Albain KS Barlow WE Shak S | 2010 | Lancet Oncol2010，11，1： | 1 |
| 17 | 2004 ASCO Annu- M Meeting Proceedings ( Post - Meeting Edition) 显示文摘 | KS Albain S Nag G Calderillo - Ruiz JP | 2004 | J Clinical Oncology2004，22，14： | 1 |
| 18 | Gene Polymorphisms in cy- clophosphamide metabolism pathway, treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breastcancer显示文摘 | Yao S Barlow WE Albain KS | 2010 | Clin Cancer Res2010，16，24： | 1 |
| 19 | Adjuvant ehemohormonal therapy for primary breast cancer should he sequential instead of concurrent: initial results from intergroup trial 0100 (SWOG 8814) 显示文摘 | Albain KS Green S J Racsin PM | 2002 | Proc Am Soc Clin Oncol2002，21，1： | 1 |
| 20 | Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays显示文摘 | Albain KS Paik S van't Veer L | 2009 | Breast2009，18，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员